{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:48:46Z","timestamp":1778003326080,"version":"3.51.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT2002193"],"award-info":[{"award-number":["GNT2002193"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2025894"],"award-info":[{"award-number":["2025894"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2016909"],"award-info":[{"award-number":["2016909"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11096-024-01849-0","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T08:47:50Z","timestamp":1735030070000},"page":"443-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Opioid prescribing prevalence and initiation rates in Victoria, Australia: insights from primary care data during a period of opioid policy changes (2017\u20132022)"],"prefix":"10.1007","volume":"47","author":[{"given":"Zeynep","family":"Balikci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulyana","family":"Kondratova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3209","authenticated-orcid":false,"given":"Louisa","family":"Picco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5033-6248","authenticated-orcid":false,"given":"Ting","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,24]]},"reference":[{"issue":"4","key":"1849_CR1","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/S2468-2667(22)00013-5","volume":"7","author":"C Ju","year":"2022","unstructured":"Ju C, Wei L, Man KK, et al. Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study. Lancet Public Health. 2022;7(4):e335\u201346.","journal-title":"Lancet Public Health"},{"key":"1849_CR2","unstructured":"United Nations Office on Drugs and Crime (ONODC). World Drug Report 2023. ONODC; 2023."},{"key":"1849_CR3","unstructured":"Penington Institute, Australia's Annual Overdose Report 2022. Penington Institute Melbourne; 2022."},{"key":"1849_CR4","unstructured":"Therapeutic Goods Administration. Prescription opioids: What changes are being made and why? Available from: https:\/\/www.tga.gov.au\/products\/medicines\/prescription-medicines\/prescription-opioids-hub\/prescription-opioids-what-changes-are-being-made-and-why (2021). Accessed 11 Oct 2023."},{"issue":"1","key":"1849_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.18773\/austprescr.2018.006","volume":"41","author":"DM Roberts","year":"2018","unstructured":"Roberts DM, Nielsen S. Changes for codeine. Aust Prescr. 2018;41(1):2\u20133.","journal-title":"Aust Prescr"},{"key":"1849_CR6","unstructured":"Department of Health, National Real Time Prescription Monitoring (RTPM). Australian Government, Editor. Canberra; 2022."},{"issue":"10","key":"1849_CR7","doi-asserted-by":"publisher","first-page":"e483","DOI":"10.1016\/S2468-2667(19)30156-2","volume":"4","author":"KM Verhamme","year":"2019","unstructured":"Verhamme KM, Bohnen AM. Are we facing an opioid crisis in Europe? Lancet Public Health. 2019;4(10):e483\u20134.","journal-title":"Lancet Public Health"},{"issue":"5","key":"1849_CR8","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1071\/PY20270","volume":"27","author":"D Busingye","year":"2021","unstructured":"Busingye D, Daniels B, Brett J, et al. Patterns of real-world opioid prescribing in Australian general practice (2013\u201318). Aust J Prim Health. 2021;27(5):416\u201324.","journal-title":"Aust J Prim Health"},{"issue":"1","key":"1849_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12875-022-01783-y","volume":"23","author":"S Reid","year":"2022","unstructured":"Reid S, Day C, White N, et al. Opioid prescribing in general practice: an Australian cross-sectional survey. BMC Prim Care. 2022;23(1):171.","journal-title":"BMC Prim Care"},{"issue":"1","key":"1849_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.13792","volume":"85","author":"S Lalic","year":"2019","unstructured":"Lalic S, Ilomaki J, Bell JS, et al. Prevalence and incidence of prescription opioid analgesic use in Australia. Br J Clin Pharmacol. 2019;85(1):202\u201315.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1849_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5694\/mja2.52259","volume":"220","author":"S Nielsen","year":"2024","unstructured":"Nielsen S, Xia T. Interventions for reducing the prescribing of pharmaceutical opioids in Australia: are they effectively reducing opioid harm? Med J Aust. 2024;220(6):311\u20132.","journal-title":"Med J Aust"},{"key":"1849_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.drugpo.2018.10.013","volume":"64","author":"T-C Chen","year":"2019","unstructured":"Chen T-C, Chen L-C, Kerry M, et al. Prescription opioids: regional variation and socioeconomic status\u2013evidence from primary care in England. Int J Drug Policy. 2019;64:87\u201394.","journal-title":"Int J Drug Policy"},{"issue":"2","key":"1849_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s11096-020-01079-0","volume":"43","author":"AD Adewumi","year":"2021","unstructured":"Adewumi AD, Maravilla JC, Alati R, et al. Duration of opioid use and association with socioeconomic status, daily dose and formulation: a two-decade population study in Queensland. Aust Int J Clin Pharm. 2021;43(2):340\u201350.","journal-title":"Aust Int J Clin Pharm"},{"issue":"1","key":"1849_CR14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/add.15071","volume":"116","author":"P B\u00f6ckerman","year":"2021","unstructured":"B\u00f6ckerman P, Haapanen M, Hakulinen C, et al. Determinants of prescription opioid use: population-based evidence from Finland. Addiction. 2021;116(1):170\u20135.","journal-title":"Addiction"},{"issue":"5","key":"1849_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067746","volume":"13","author":"S Nielsen","year":"2023","unstructured":"Nielsen S, Buchbinder R, Pearce C, et al. Cohort profile: using primary care data to understand opioid prescribing, policy impacts and clinical outcomes (OPPICO) in Victoria, Australia. BMJ Open. 2023;13(5): e067746.","journal-title":"BMJ Open"},{"key":"1849_CR16","unstructured":"Australian Bureau of Statistics, Socio-economic indexes for areas (SEIFA). Australian Bureau of Statistics; 2016."},{"issue":"2","key":"1849_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/00223890802634175","volume":"91","author":"S Coxe","year":"2009","unstructured":"Coxe S, West SG, Aiken LS. The analysis of count data: a gentle introduction to Poisson regression and its alternatives. J Pers Assess. 2009;91(2):121\u201336.","journal-title":"J Pers Assess"},{"issue":"12","key":"1849_CR18","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.jpain.2019.04.007","volume":"20","author":"MN Wilson","year":"2019","unstructured":"Wilson MN, Hayden JA, Rhodes E, et al. Effectiveness of prescription monitoring programs in reducing opioid prescribing, dispensing, and use outcomes: a systematic review. J Pain. 2019;20(12):1383\u201393.","journal-title":"J Pain"},{"issue":"11","key":"1849_CR19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1056\/NEJMsa1807069","volume":"380","author":"W Zhu","year":"2019","unstructured":"Zhu W, Chernew ME, Sherry TB, et al. Initial opioid prescriptions among US commercially insured patients, 2012\u20132017. N Engl J Med. 2019;380(11):1043\u201352.","journal-title":"N Engl J Med"},{"issue":"15","key":"1849_CR20","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016. JAMA. 2016;315(15):1624\u201345.","journal-title":"JAMA"},{"key":"1849_CR21","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1007\/s11606-024-08947-9","volume":"39","author":"AC Bradford","year":"2024","unstructured":"Bradford AC, Nguyen T, Schulson L, et al. High-dose opioid prescribing in individuals with acute pain: assessing the effects of us state opioid policies. J General Intern Med. 2024;39:2689\u201397.","journal-title":"J General Intern Med"},{"issue":"3","key":"1849_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1136\/ejhpharm-2017-001460","volume":"26","author":"W Fang","year":"2019","unstructured":"Fang W, Liu T, Gu Z, et al. Consumption trend and prescription pattern of opioid analgesics in China from 2006 to 2015. Eur J Hosp Pharm. 2019;26(3):140\u20135.","journal-title":"Eur J Hosp Pharm"},{"issue":"9","key":"1849_CR23","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1111\/bcp.15448","volume":"88","author":"J Mirabella","year":"2022","unstructured":"Mirabella J, Ravi D, Chiew AL, et al. Prescribing trend of tapentadol in a Sydney local health district. Br J Clin Pharmacol. 2022;88(9):3929\u201335.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"1849_CR24","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/add.15653","volume":"117","author":"T Lam","year":"2022","unstructured":"Lam T, Hayman J, Berecki-Gisolf J, et al. Pharmaceutical opioid poisonings in Victoria, Australia: rates and characteristics of a decade of emergency department presentations among nine pharmaceutical opioids. Addiction. 2022;117(3):623\u201336.","journal-title":"Addiction"},{"issue":"9","key":"1849_CR25","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/15563650.2022.2074857","volume":"60","author":"BS Chan","year":"2022","unstructured":"Chan BS, Mirabella J, Allen K, et al. Tapentadol exposures and poisonings in Australia. Clin Toxicol. 2022;60(9):1063\u20136.","journal-title":"Clin Toxicol"},{"key":"1849_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2024.2427881","author":"J Suresh","year":"2024","unstructured":"Suresh J, Shukla S, Vivekanandan K, et al. Tapentadol: navigating the complexities of abuse, patient safety and regulatory measures. Curr Med Res Opin. 2024. https:\/\/doi.org\/10.1080\/03007995.2024.2427881.","journal-title":"Curr Med Res Opin."},{"key":"1849_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107697","volume":"206","author":"A Peacock","year":"2020","unstructured":"Peacock A, Gisev N, Memedovic S, et al. Opioid use and harms associated with a sustained-release tapentadol formulation: a post-marketing surveillance study. Drug Alcohol Depend. 2020;206: 107697.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"1849_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s40360-018-0219-0","volume":"19","author":"MM Islam","year":"2018","unstructured":"Islam MM, McRae IS, Mazumdar S, et al. Prescription opioid dispensing in New South Wales, Australia: spatial and temporal variation. BMC Pharmacol Toxicol. 2018;19(1):30.","journal-title":"BMC Pharmacol Toxicol"},{"issue":"Suppl 1","key":"1849_CR29","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2106\/JBJS.20.00237","volume":"102","author":"KJ Templeton","year":"2020","unstructured":"Templeton KJ. Sex and gender issues in pain management. J Bone Joint Surg. 2020;102(Suppl 1):32\u20135.","journal-title":"J Bone Joint Surg"},{"issue":"1","key":"1849_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/bja\/aet127","volume":"111","author":"EJ Bartley","year":"2013","unstructured":"Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth. 2013;111(1):52\u20138.","journal-title":"Br J Anaesth"},{"issue":"9","key":"1849_CR31","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1111\/pme.12773","volume":"16","author":"G Campbell","year":"2015","unstructured":"Campbell G, Nielsen S, Larance B, et al. Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the pain and opioids in treatment (POINT) cohort. Pain Med. 2015;16(9):1745\u201358.","journal-title":"Pain Med"},{"key":"1849_CR32","doi-asserted-by":"publisher","unstructured":"Glover JD, Hetzel DM, Tennant SK. The socioeconomic gradient and chronic illness and associated risk factors in Australia. Aust New Zealand Health Policy. 2004;1(1):8. https:\/\/doi.org\/10.1186\/1743-8462-1-8. PMID: 15679942; PMCID: PMC546403","DOI":"10.1186\/1743-8462-1-8"},{"issue":"1","key":"1849_CR33","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/24740527.2022.2104699","volume":"6","author":"N Atkins","year":"2022","unstructured":"Atkins N, Mukhida K. The relationship between patients\u2019 income and education and their access to pharmacological chronic pain management: a scoping review. Can J Pain. 2022;6(1):142\u201370.","journal-title":"Can J Pain"},{"key":"1849_CR34","unstructured":"Australian Commission on Safety and Quality in Health Care. Opioid medicines dispensing, all ages, from 2016\u20132017 to 2020\u20132021; 2021; Available from: https:\/\/www.safetyandquality.gov.au\/our-work\/healthcare-variation\/opioid-medicines-dispensing-all-ages-2016-17-2020-21#:~:text=What%20we%20found,Australian%20Atlas%20of%20Healthcare%20Variation. Accessed 11 Oct 2023."},{"issue":"9","key":"1849_CR35","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/jech.54.9.714","volume":"54","author":"H Richards","year":"2000","unstructured":"Richards H, McConnachie A, Morrison C, et al. Social and gender variation in the prevalence, presentation and general practitioner provisional diagnosis of chest pain. J Epidemiol Community Health. 2000;54(9):714\u20138.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"1849_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12875-023-01976-z","volume":"24","author":"R Haas","year":"2023","unstructured":"Haas R, Gorelik A, Busija L, et al. Prevalence and characteristics of musculoskeletal complaints in primary care: an analysis from the population level and analysis reporting (POLAR) database. BMC Prim Care. 2023;24(1):40.","journal-title":"BMC Prim Care"},{"key":"1849_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2020.104189","volume":"141","author":"C Imai","year":"2020","unstructured":"Imai C, Hardie R-A, Franco GS, et al. Harnessing the potential of electronic general practice pathology data in Australia: an examination of the quality use of pathology for type 2 diabetes patients. Int J Med Inform. 2020;141: 104189.","journal-title":"Int J Med Inform"},{"key":"1849_CR38","unstructured":"RACGP, General Practice Health of the Nation 2023, The Royal Australian College of General Practitioners East Melbourne, VIC; 2023."},{"issue":"2","key":"1849_CR39","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/bcp.15577","volume":"89","author":"M Jung","year":"2023","unstructured":"Jung M, Lukose D, Nielsen S, et al. COVID-19 restrictions and the incidence and prevalence of prescription opioid use in Australia\u2013a nationwide study. Br J Clin Pharmacol. 2023;89(2):914\u201320.","journal-title":"Br J Clin Pharmacol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01849-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-024-01849-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-024-01849-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T20:45:59Z","timestamp":1742330759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-024-01849-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1849"],"URL":"https:\/\/doi.org\/10.1007\/s11096-024-01849-0","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors report no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}